Sanofi-Aventis U.S. Award
Sanofi-Aventis/American Society for Micorbiology
All Regions
04/01/2009
$20,000
sanofi-aventis U.S. Award
ASM's premier award in antimicrobial chemotherapy research; it stimulates research and honors outstanding accomplishment in antimicrobial chemotherapy. Nominees must be actively engaged in research involving development of new agents, investigation of antimicrobial action or resistance to antimicrobial agents, and/or the pharmacology, toxicology or clinical use of those agents. Nominees must not have served on the ICAAC Program Committee within the past two years.

Award: A cash prize of $20,000, a commemorative medal, and travel to ICAAC where the laureate delivers the sanofi-aventis U.S. Award Lecture. ASM awards are granted at the discretion of award selection committees and may not be awarded every year.

Deadline: April 1.

Nominations: Nominations will be considered without updating for three years; self-nominations will not be accepted. Nominations must consist of the following:

*Curriculum vitae, including a list of publications.

*Letter of nomination. Describe the nominee's outstanding accomplishment in antimicrobial chemotherapy, including a list of the ten most relevant publications to the award.

*Letters of support. Two letters of support should come from two people, other than the nominator, who are familiar with the nominee's accomplishments.

No more than one of the three letters may be from the nominee's institution or the same institution.
Email all nomination components to awards@asmusa.org.
Clinical Pharmacist, Established Investigator, Microbiologist, Pharmacist, Pharmacy Faculty, Scientist, Toxicologist
Honors & Awards of the American College of Clinical Pharmacology
American College of Clinical Pharmacology
All Regions
12/31/2008
$1,000

Announcement & Request for nominations

Honors & Awards of the American College of Clinical Pharmacology

The College's Honors & Awards Committee makes recommendations to the Board of Regents on awards, based upon nominations received from the membership. The College cordially invites nominations for all awards from ACCP members, fellows, and, in the case of the McKeen Cattell Award, from all interested readers of the Journal of Clinical Pharmacology.

All awards consist of an appropriately inscribed certificate or plaque, and payment of all expenses incurred in connection with attendance at the awards ceremony during the annual meeting. In addition, the Tanabe Young Investigator and McKeen Cattell Memorial Awards carry honoraria of $1000 each. With the exception of the McKeen Cattell Award and Tanabe Young Investigator Award, each awardee is expected to give an approximately 20-30 minute address on a subject related to the basis for the award and to submit a short manuscript based on the talk, as suitable for publication in the Journal of Clinical Pharmacology.

Materials Requested: Nominations should consist of a detailed letter summarizing the individual's accomplishments or major basis for the nomination or specific reasons for selecting a particular Journal of Clinical Pharmacology publication in the case of the McKeen Cattell award.

All nominations should be sent by December 31, 2008 to:

Chairman, Honors and Awards Committee
American College of Pharmacology
3 Ellinwood Court
New Hartford, NY 13413-1105
Alternatively, nominations can be submitted via email to: Susan Ulrich

Clinical Pharmacist, Distinguished Investigator, Senior Investigator, Young Investigator, Mentor
Request for 2009 Award Nominations American College of Clinical Pharmacology
American College of Clinical Pharmacology
All Regions
12/31/2008
$1,000
Request for 2009 Award Nominations
American College of Clinical Pharmacology
T he College's Honors & Awards Committee makes recommendations to the
Board of Regents on awards, based upon nominations received. The College
cordially invites nominations for all awards.
All awards consist of an appropriately inscribed certificate or plaque, and payment of
all expenses incurred in connection with attendance at the awards ceremony during
the annual meeting. In addition, the Tanabe Young Investigator and McKeen Cattell
Memorial Awards carry honoraria of $1000 each. With the exception of the McKeen
Cattell Award and Tanabe Young Investigator Award, each awardee is expected to give
an approximately 20-30 minute address on a subject related to the basis for the award
and to submit a short manuscript based on the talk, as suitable for publication in the
Journal of Clinical Pharmacology.
DISTINGUISHED INVESTIGATOR AWARD
This award is given yearly and is primarily intended to recognize superior scientific expertise and
accomplishments by a senior investigator, usually involving a distinct area of research in basic or
clinical pharmacology for which the individual is internationally known. The candidate need not
be a member or fellow of the College.
NATHANIEL T. KWIT MEMORIAL DISTINGUISHED
SERVICE AWARD
This award is given in honor of the memory of the late Nathaniel T. Kwit, M.D., FCP, a founding
Fellow of the College, who served as a Regent for 5 years and as Treasurer for 20 years. The primary
intent of this award is to recognize accomplishments of a general nature which benefit the
field of clinical pharmacology. These may be in the area of teaching, administration, service with
ACCP, long-term and wide ranging scientific studies having practical importance, and other service-
related functions. It is differentiated for the Distinguished Investigator Award in that it is not
intended to recognize any distinct area of scientific investigation, but rather an overall contribution
to the field. The candidate need not be an ACCP member or fellow.
HONORARY FELLOWSHIP AWARD
This is given yearly to a non-member of the College and is meant to recognize primary activities
within the immediate domain of clinical pharmacology. The award recognizes overall contributions
to the field, rather than for any particular scientific work, by a senior investigator or authority
having a national or international reputation in the scientific, public service, legislative, governmental
or other area of endeavor impacting on the field.
Request for 2009 Award Nominations
American College of Clinical Pharmacology, continued
THE MCKEEN CATTELL MEMORIAL AWARD
The McKeen Cattell Memorial Award replaces the Harry Gold Award. This award is made in the honor of the memory
of the late McKeen Cattell, M.D., Ph.D., F.C.P., the first editor of the Journal of Clinical Pharmacology and cofounder
of the College. It is made yearly to the first author on an outstanding research paper published in the journal,
and appearing during the calendar year preceding the Annual Meeting at which the award is presented.
BRISTOL-MYERS SQUIBB MENTORSHIP IN CLINICAL PHARMACOLOGY
AWARD
This award is given on a bi-yearly basis, beginning with the 2007 Annual Meeting. It is funded by a grant from Bristol-
Myers Squibb. The award recognizes sustained excellence in clinical pharmacology mentorship in an academic, regulatory
and/or industrial setting. The nominee should exhibit demonstrated promotion of the field of clinical pharmacology
with emphasis on training/guidance of junior scientists and/or colleagues.
Materials Requested: Nominations should include at least two letters of support highlighting the setting, duration and
extent of mentorship from mentored scientists.
TANABE YOUNG INVESTIGATOR AWARD
This award is given on a bi-yearly basis, beginning with the 1990 Annual Meeting. It is funded by a grant from Tanabe
Research Labs, USA. The award is meant to recognize the scientific contributions of a young investigator, usually less
than 40 years of age, at a relatively early stage of his/her career, who has made unusual strides in research relating to
clinical pharmacology and whose career shows promise of outstanding achievements. The candidate need not be an
ACCP member or fellow.
Materials Requested: Nominations should consist of a detailed letter summarizing the
individual's accomplishments or major basis for the nomination or specific reasons
for selecting a particular Journal of Clinical Pharmacology publication in the
case of the McKeen Cattell award.
All nominations should be sent by December 31, 2008 to:
Chairman, Honors and Awards Committee
American College of Pharmacology
3 Ellinwood Court
New Hartford, NY 13413-1105
Nominations can be submitted via email to: SUE@ACCP1.org
Clinical Pharmacist, Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, New Investigator, Young Investigator, Young Scientist
American Chemical Society Award for Computers in Chemical and Pharmaceutical Research
American Chemical Society/Schrödinger
All Regions
11/01/2008
$5,000
ACS Award for Computers in Chemical and Pharmaceutical Research

Purpose: To recognize and encourage the use of computers in the advancement of the chemical and biological sciences.
Nature: The award consists of $5,000 and a certificate. Up to $1,000 for travel expenses to the meeting at which the award will be presented will be reimbursed.

Eligibility: The award will be granted without regard to age or nationality for outstanding achievement in the use of computers in research, development, or education in the chemical and biological sciences.

Deadline: November 1 (annual review).

Establishment & Support: Schrödinger will begin sponsoring the award with the 2008 presentation. The ACS financed the award from 1999 to 2001. Accelrys, Inc. sponsored the award from 2002 to 2007. IBM North America, Scientific and Technical Systems and Solutions sponsored the award from 1996 to 1998. The Digital Equipment Corporation established the award in 1984 and sponsored it through 1995.

Contact Information

Awards Office
American Chemical Society
1155 16th Street NW
Washington, DC 20036-4801
Phone: (202) 872-4408
Fax: (202) 776-8008
awards@acs.org
Chemist, Technologist, Clinical Pharmacist, Biochemist, Biologist
Pharmacy Resident Practice-Based Research Grant
American Society of Health-System Pharmacists (ASHP) Research and Education Foundation
All Regions
10/31/2008
$5,000

Pharmacy Resident Practice-Based Research Grant

Sponsored by the ASHP Foundation
Application Available: April 15, 2008
Application Deadline: October 31, 2008

Description
The Pharmacy Resident Practice-Based Research Grant Program supports practice-based research in medication use conducted by residents in ASHP-accredited pharmacy residency programs and residents in pharmacy residency programs that have submitted an application for ASHP accreditation. Practice-based research affects a wide range of medication-use topics, including patient education; patient outcomes and effectiveness of medication therapy; health care quality; medication use in minority, elderly and other special populations; medication costs and financing; information for health care policymakers; and access to medications.

A secondary goal of the program is to develop pharmacy residents’ research skills while fostering development of mentoring relationships with more experienced senior investigators.

Applications for this research grant program should emphasize study objectives that focus on practice-based medication-use research, sound research methods that support the study objectives, interdisciplinary collaborations, the potential for the study findings to be replicated, and prudent use of grant funds.

Eligibility Criteria
The proposed research must involve practice-based research in medication use that is conducted by a pharmacy resident in an ASHP-accredited residency program or a pharmacy resident in a residency program that has submitted an application for ASHP accreditation. The principal investigator must have a senior investigator participate on the research team as a mentor/advisor. In the application process and grant progress reports, evidence must be included regarding the support and involvement of the senior investigator.

The proposed study must be submitted to an institutional review board (IRB) for approval. Evidence of IRB approval must be provided to the ASHP Research and Education Foundation upon acceptance of the grant award. Grant funds will not be disbursed until evidence of IRB approval has been received.

Funding Information
Six $5,000 grants will be awarded. Grants will be awarded to pharmacy residents to provide funding for specific health services research related to medication use and are not intended for long-term support of research programs. Facilities and administrative cost rates that do not exceed 8% of the total requested budget are allowed.

Application Process
Full eligibility requirements and application procedures are provided in the request for applications and application instructions below.

Selection Criteria
Grant applications will be reviewed by a selection panel using the following criteria:

• Rationale-10 points
• Significance-10 points
• Hypothesis/Objectives-20 points
• Study Methods-40 points
• Project Scope and Timeline-5 points
• Personnel and Facilities-15 points

Deadlines
Deadline: October 31, 2008

American Society of Health-System Pharmacists (ASHP) Research and Education Foundation
7272 Wisconsin Avenue
Bethesda, Maryland 20814
Phone: (301) 664-8612
Fax: (301) 634-5712
E-mail: foundation@ashp.org
Web site: www.ashpfoundation.org

Clinical Pharmacist, Pharmacy Resident
Junior Investigator Research Grant
American Society of Health-System Pharmacists (ASHP) Research and Education Foundation
All Regions
02/16/2009
$18,000

Junior Investigator Research Grant
Sponsored by the ASHP Foundation
Application Available: June 1, 2008
Application Deadline: February 16, 2009

Description
The Junior Investigator Research Grant Program supports health services research in medication use that is conducted by pharmacist junior investigators. Health services research affects a wide range of medication-use topics including patient education; patient outcomes and effectiveness of medication therapy; health care quality; medication use in minority, elderly and other special populations; medication costs and financing; information for health care policymakers; and access to medications. A secondary goal of the program is to develop and strengthen the skills of newer pharmacist investigators while fostering development of mentoring relationships with more experienced senior investigators.

Applications for this research grant program should emphasize:

1) Project objectives that address health services research related to medication use;
2) prudent use of grant funds;
3) a sound research methodology that supports the project objectives;
4) mentoring activities between a senior investigator/advisor and the junior investigator;
5) interdisciplinary collaboration;
6) the potential for projects to be replicated in other health care facilities; and
7) the impact that the results of the project will have on medication use.
Preference will be given to research projects with the potential to yield strong scientific evidence that can be applied to practice.

Eligibility Criteria
The proposed research must involve health services research in medication use that is conducted by a pharmacist junior investigator. The principal investigator must be a new researcher within 5 years of completion of his/her terminal degree or postgraduate training or have professional experience greater than 5 years and no more than two externally funded research projects as a principal investigator.

The principal investigator must be a licensed pharmacist and multidisciplinary research teams are encouraged. Also, the principal investigator must have a senior investigator participate on the research team as a mentor/advisor. In the application process and grant progress reports, evidence must be included regarding the support and involvement of the senior investigator.

The proposed study must be submitted to an institutional review board (IRB) for approval. Evidence of IRB approval must be provided to the ASHP Research and Education Foundation upon acceptance of the grant award. Grant funds will not be disbursed until evidence of IRB approval has been received.

Funding Information
Two $18,000 grants will be awarded. Grants are awarded to junior investigators to provide funding for specific health services research related to medication use and are not intended for long-term support of research programs.

One-third of the total grant will be provided with the notice of the award. One-third will be provided following receipt of a written progress report submitted at the midpoint of the timeline for study completion. The remaining one-third will be provided upon receipt of a final report that is due within 60 days of project completion.

Application Process
Pharmacists interested in applying for funding should refer to the request for proposals and application instructions for full eligibility requirements and application procedures. Please check the Programs Calendar periodically for information about future offerings.

Selection Criteria
Grant applications will be judged by a selection panel using the following criteria:

• Objectives-25 points
• Rationale-10 points
• Significance-15 points
• Study Methods-25 points
• Project Scope and Timeline-10 points
• Personnel and Facilities-15 points

Deadlines
Deadline: February 16, 2009

American Society of Health-System Pharmacists (ASHP) Research and Education Foundation
7272 Wisconsin Avenue
Bethesda, Maryland 20814
Phone: (301) 664-8612
Fax: (301) 634-5712
E-mail: foundation@ashp.org
Web site: www.ashpfoundation.org

Clinical Pharmacist, Junior Investigator
Federal Services Junior Investigator Research Grant
American Society of Health-System Pharmacists (ASHP) Foundation/Abbott
All Regions
01/09/2009
$25,000

Federal Services Junior Investigator Research Grant
Supported by Abbott
Application Available: May 1, 2008
Application Deadline: January 9, 2009

Description
The Federal Services Junior Investigator Research Grant Program supports research efforts critical to the study of medication adherence and persistence in older patients who receive care through the Veterans Administration, the Department of Defense, and the Public Health Service. These medication adherence and persistence studies should focus on individuals with either autoimmune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease. A secondary goal of the program is to develop and strengthen the skills of newer researchers in the federal services and foster mentoring of these researchers by more experienced senior investigators.

Applications for this research grant program should emphasize study objectives that focus on optimal medication outcomes, sound research methods that support the study objectives, interdisciplinary collaborations, the potential for the project to be replicated in other federal health systems, and prudent use of grant funds.

Eligibility Criteria
The research must focus on the topic area. The proposed research must be conducted in a Veterans Administration, Department of Defense, or Public Health Service facility. The principal investigator for the project must be a licensed pharmacist, physician, or nurse. The principal investigator must be a new researcher within 5 years of completion of his/her terminal degree or postgraduate training or have professional experience greater than 5 years and no more than two externally funded research projects as a principal investigator. The senior investigator must be a licensed pharmacist, physician, or nurse. The proposed research must be submitted to an institutional review board (IRB) for approval. Evidence of IRB approval must be provided to the ASHP Foundation upon acceptance of the grant award. Grant funds will not be disbursed until evidence of IRB approval or evidence of exemption from IRB review has been received. The research must comply with the NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research. The study timeline should not exceed 2 years beyond project initiation.

Funding Information
Two $25,000 grants will be awarded. Grants are awarded to junior investigators to provide funding for research related to medication adherence and persistence studies that focus on individuals with either autoimmune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease and are not intended for long-term support of research programs. One-third of the total grant will be provided with the notice of the award. One-third will be provided following receipt of a written progress report submitted at the midpoint of the timeline for study completion. The remaining one-third will be provided upon receipt of a final report that is due within 60 days of project completion.

Application Process
Pharmacists, physicians, and nurses interested in applying for funding should refer to the request for proposals and application instructions for full eligibility requirements and application procedures. Please check the Programs Calendar periodically for information about future offerings.

Selection Criteria
Grant applications will be judged by a selection panel using the following criteria:

• Rationale-10 points
• Significance-10 points
• Hypothesis/Objectives-20 points
• Study Methods-40 points
• Project Scope and Timeline-5 points
• Personnel and Facilities-15 points

Deadlines
Deadline: January 9, 2009

American Society of Health-System Pharmacists (ASHP) Research and Education Foundation
7272 Wisconsin Avenue
Bethesda, Maryland 20814
Phone: (301) 664-8612
Fax: (301) 634-5712
E-mail: foundation@ashp.org
Web site: www.ashpfoundation.org

Junior Investigator, Clinical Pharmacist
The Bernard B.Brodie Award in Drug Metabolism
American Society for Pharmacology and Experimental Therapeutics (ASPET)
All Regions
09/15/2009
$2,000
THE BERNARD B. BRODIE AWARD IN DRUG METABOLISM FOR 2010
(Deadline for submission of nominations is September 15, 2009)

The B. B. Brodie Award in Drug Metabolism has been established to honor the fundamental contributions of Bernard B. Brodie in the field of drug metabolism and disposition. The Award is presented biennially in even years to recognize outstanding original research contributions in drug metabolism and disposition, particularly those having a major impact on future research in the field. The B. B. Brodie Award is sponsored by the American Society for Pharmacology and Experimental Therapeutics (ASPET) Division for Drug Metabolism, and funds to support the award come from members’ contributions.

The award consists of a $2,000 honorarium, a commemorative medal, hotel and economy airfare to the award ceremony at the annual meeting. A lecture, delivered by the awardee at the annual meeting, describing appropriate research accomplishments and their future direction, will be published in Drug Metabolism and Disposition.

There are no restrictions on institutional affiliation, and a candidate need not be a member of the Society. The only restriction for the Award is that supporting research accomplishments must not be used to win any other major award. Only one nominator is necessary, although more are acceptable, and the nominators need not be members of ASPET. Selection of an awardee will be made biennially by the B.B. Brodie Award Committee, appointed by the President of ASPET with input from the Division for Drug Metabolism.

Nominations shall be submitted electronically to markin@aspet.org and shall consist of:

Nominating letter and no more than five supporting letters detailing accomplishments of the nominee.

List of, and comments on, the outstanding papers.

Brief biographical sketch of the candidate.

Candidate’s curriculum vitae and bibliography.

Receipt date for nominations for the Bernard B. Brodie Award will be 5:00 pm on September 15, 2009 for an award to be presented at Experimental Biology ’10 in Anaheim, CA.
Clinical Pharmacist, Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, Established Investigator, Pharmacy Faculty, Senior Investigator, Senior Researcher
Benedict R. Lucchesi Distinguished Lectureship in Cardiac Pharmacology for 2009
American Society for Pharmacology and Experimental Therapeutics (ASPET)
All Regions
10/15/2008
$1,000
Deadline for submission of nominations for the 2008 Benedict R. Lucchesi Distinguished Lectureship in Cardiac Pharmacology is October 15, 2008

The Benedict R. Lucchesi Award in Cardiac Pharmacology was established to honor Dr. Lucchesi’s lifelong scientific contributions to our better understanding and appreciation of pharmacological treatment and prevention of cardiovascular disease and for his mentoring of countless prominent functional (in vivo) cardiovascular pharmacologists.
The Benedict R. Lucchesi Award is a biennial award, consisting an honorarium of $1,000, a custom-designed crystal bowl depicting the named Lectureship, and up to $2,000 travel expenses including registration to the annual spring American Society for Pharmacology and Experimental Therapeutics (ASPET) meeting. A recipient will be selected and invited to deliver a state-of-the-art lecture on recent advances in the field of cardiac and electropharmacology at the spring ASPET meeting (Division’s programming session). The presentation of his/her research should be of  broad interest and contribute to the growth of the Cardiovascular Pharmacology Division.

There are no restrictions on institutional affiliation, nationality, or age of the candidate, but the recipient must be a member of the ASPET. Nominations must be made by a member of the ASPET, and no member may nominate more than one candidate per year. Final selection of the recipient will
be made by the Award Committee of the Division for Cardiovascular Pharmacology.

Nominations should consist of not more than five letters from nominators describing the contributions
to cardiac and electropharmacology of the candidate that make him/her eligible for this Award and
listing of his/her major contributions, together with a complete curriculum vitae. To ensure
consideration, all information must be submitted electronically to: Margie Arkin (markin@aspet.org), American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, MD 20814-3995 no later than October 15, 2008.
Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, Established Investigator, Pharmacist, Pharmacy Faculty, Senior Investigator, Senior Researcher
American Diabetes Association (ADA)-Association of Subspecialty Professors (ASP) Young Investigator Innovation Award in Geriatric Endocrinology
American Diabetes Association (ADA)-Association of Subspecialty Professors (ASP)
All Regions
01/15/2009
$150,000

ADA-ASP Young Investigator Innovation Award in Geriatric Endocrinology
Award Description: The American Diabetes Association (ADA)-Association of Subspecialty Professors (ASP) Young Investigator Innovation Award in Geriatric Endocrinology provides grant support to new investigators. This program supports entry-level faculty to integrate geriatrics with novel basic, clinical, or health services diabetes research. This award supports pilot and feasibility studies that may lack preliminary data, but offer considerable promise for the cure, prevention, or treatment of diabetes in an aging population.
Support: Awards are a maximum of $75,000 per year for up to two years. No indirect costs may be requested.
Deadline Dates: July 15, 2008 for January 1, 2009 funding and January 15, 2009 for July 1, 2009 funding.

Call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383). Our hours of operation are Monday - Friday, 8:30 AM - 8 PM Eastern Standard Time.
Or write to us:
American Diabetes Association
ATTN: National Call Center
1701 North Beauregard Street
Alexandria, VA 22311

Allied Health Professional, Behavioral Scientist, Clinical Pharmacist, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, New Investigator, Physician Researcher, Public Health Expert, Public Health Worker, Young Investigator, Young Scientist, Social Scientist, Health Services Researcher

2next